Sidley Austin to Reveal Guidance on UK Data Protection and Pharmacovigilance

LONDON - June 6, 2013 - PRLog -- The new presentation will provide:

• Explanation of new UK Guidance on Data Protection and PV
• Understanding of background to EU data protection and PV
• Development of the UK Guidance
• Outline of the scope and main elements of the UK Guidance

The conference will aim to offer delegates with guidance on the main points to consider when presenting a PSUR to external regulatory bodies and tackle the issues and importance of adverse event reporting.

Attendees include EMA, Abbott, Federal Agency for Medicial and Health Products, Teva, Merck Serono, Roche, Gensyme, Johnson & Johnson, Novo Nordisk, Pharsafer, NDA Regulatory Science, Eli Lilly, MorphoSys plus many more...

"...this Pharmacovigilance event brings experienced representative stakeholders together to generate a mutually-positive dialogue and cross-fertilized consensus on understanding, sharing, benchmarking and improving the way we operate within the discipline of Pharmacovigilance" - Abbott

To find out more visit www.pharmacovigilance -event.com